Intralesional collagenase Clostridium histolyticum in the management of Peyronie’s disease: current best practice

The use of Clostridium histolyticum collagenase (CCH) has become increasingly widespread for the treatment of Peyronie’s disease (PD) in recent years. Numerous trials have confirmed both its safety and efficacy in appropriately selected patients with this condition. The purpose of this review is to...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic Advances in Urology 2018-04, Vol.10 (4), p.139-153
Main Authors: Cwikla, Daniel J., Yafi, Faysal A.
Format: Article
Language:English
Subjects:
Connective tissue diseases
Penis
Reviews
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c462t-5a96c946a38350a3be07e5179b46bf172ff484535cafac0935e9344cb850e43b3
cites cdi_FETCH-LOGICAL-c462t-5a96c946a38350a3be07e5179b46bf172ff484535cafac0935e9344cb850e43b3
container_end_page 153
container_issue 4
container_start_page 139
container_title Therapeutic Advances in Urology
container_volume 10
creator Cwikla, Daniel J.
Yafi, Faysal A.
description The use of Clostridium histolyticum collagenase (CCH) has become increasingly widespread for the treatment of Peyronie’s disease (PD) in recent years. Numerous trials have confirmed both its safety and efficacy in appropriately selected patients with this condition. The purpose of this review is to examine pivotal trials demonstrating the efficacy of CCH, revisit viable candidates for treatment with intralesional injection therapy, and provide a summary of injection technique and appropriate management of patients receiving this treatment at the time of therapy and in follow up.
doi_str_mv 10.1177/1756287218755020
format article
fullrecord <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5851106</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1756287218755020</sage_id><sourcerecordid>2016532436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-5a96c946a38350a3be07e5179b46bf172ff484535cafac0935e9344cb850e43b3</originalsourceid><addsrcrecordid>eNp1kb1uFDEUha0IlIRAnyqyREMz4H97UkRCqwCRIkGR1JbHeyfraMZe7Bmk7XgNXo8niZcNC0Si8t93j--5B6FTSt5SqvU7qqViRjNqtJSEkQN0vL1qmDHk2X6v2RF6Uco9IUooxg7REWulIoSTY1Su4pTdACWk6Abs0zC4O4iuAF4MqUw5LMM84lUoUxo2U_D1ECKeVoBHFys6Qpxw6vEX2OQUA_z8_qPgZShQJc6xn3PeAh2UCa-z81UBXqLnvRsKvHpcT9Dth8ubxafm-vPHq8X768bXNqdGulb5VijHDZfE8Q6IBkl12wnV9VSzvhdGSC69650nLZfQciF8ZyQBwTt-gi52uuu5G2Hp4ZdVu85hdHljkwv235cYVvYufbPSSEqJqgJvHgVy-jpXC3YMxUMdUYQ0F8sIVZIzwbfo6yfofZpzHWmlOOWtqdPWlSI7yudUSoZ-3wwldpuofZpoLTn728S-4HeEFWh2QKlp_Pn1v4IPSrarng</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2313980307</pqid></control><display><type>article</type><title>Intralesional collagenase Clostridium histolyticum in the management of Peyronie’s disease: current best practice</title><source>Sage Journals GOLD Open Access 2024</source><creator>Cwikla, Daniel J. ; Yafi, Faysal A.</creator><creatorcontrib>Cwikla, Daniel J. ; Yafi, Faysal A.</creatorcontrib><description>The use of Clostridium histolyticum collagenase (CCH) has become increasingly widespread for the treatment of Peyronie’s disease (PD) in recent years. Numerous trials have confirmed both its safety and efficacy in appropriately selected patients with this condition. The purpose of this review is to examine pivotal trials demonstrating the efficacy of CCH, revisit viable candidates for treatment with intralesional injection therapy, and provide a summary of injection technique and appropriate management of patients receiving this treatment at the time of therapy and in follow up.</description><identifier>ISSN: 1756-2872</identifier><identifier>EISSN: 1756-2880</identifier><identifier>DOI: 10.1177/1756287218755020</identifier><identifier>PMID: 29560030</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Connective tissue diseases ; Penis ; Reviews</subject><ispartof>Therapeutic Advances in Urology, 2018-04, Vol.10 (4), p.139-153</ispartof><rights>The Author(s), 2018</rights><rights>The Author(s), 2018. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content</rights><rights>The Author(s), 2018 2018 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-5a96c946a38350a3be07e5179b46bf172ff484535cafac0935e9344cb850e43b3</citedby><cites>FETCH-LOGICAL-c462t-5a96c946a38350a3be07e5179b46bf172ff484535cafac0935e9344cb850e43b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851106/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2313980307?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,313,314,727,780,784,792,885,21966,25753,27853,27922,27924,27925,37012,37013,44590,44945,45333,53791,53793</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/1756287218755020?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29560030$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cwikla, Daniel J.</creatorcontrib><creatorcontrib>Yafi, Faysal A.</creatorcontrib><title>Intralesional collagenase Clostridium histolyticum in the management of Peyronie’s disease: current best practice</title><title>Therapeutic Advances in Urology</title><addtitle>Ther Adv Urol</addtitle><description>The use of Clostridium histolyticum collagenase (CCH) has become increasingly widespread for the treatment of Peyronie’s disease (PD) in recent years. Numerous trials have confirmed both its safety and efficacy in appropriately selected patients with this condition. The purpose of this review is to examine pivotal trials demonstrating the efficacy of CCH, revisit viable candidates for treatment with intralesional injection therapy, and provide a summary of injection technique and appropriate management of patients receiving this treatment at the time of therapy and in follow up.</description><subject>Connective tissue diseases</subject><subject>Penis</subject><subject>Reviews</subject><issn>1756-2872</issn><issn>1756-2880</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1kb1uFDEUha0IlIRAnyqyREMz4H97UkRCqwCRIkGR1JbHeyfraMZe7Bmk7XgNXo8niZcNC0Si8t93j--5B6FTSt5SqvU7qqViRjNqtJSEkQN0vL1qmDHk2X6v2RF6Uco9IUooxg7REWulIoSTY1Su4pTdACWk6Abs0zC4O4iuAF4MqUw5LMM84lUoUxo2U_D1ECKeVoBHFys6Qpxw6vEX2OQUA_z8_qPgZShQJc6xn3PeAh2UCa-z81UBXqLnvRsKvHpcT9Dth8ubxafm-vPHq8X768bXNqdGulb5VijHDZfE8Q6IBkl12wnV9VSzvhdGSC69650nLZfQciF8ZyQBwTt-gi52uuu5G2Hp4ZdVu85hdHljkwv235cYVvYufbPSSEqJqgJvHgVy-jpXC3YMxUMdUYQ0F8sIVZIzwbfo6yfofZpzHWmlOOWtqdPWlSI7yudUSoZ-3wwldpuofZpoLTn728S-4HeEFWh2QKlp_Pn1v4IPSrarng</recordid><startdate>20180401</startdate><enddate>20180401</enddate><creator>Cwikla, Daniel J.</creator><creator>Yafi, Faysal A.</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180401</creationdate><title>Intralesional collagenase Clostridium histolyticum in the management of Peyronie’s disease: current best practice</title><author>Cwikla, Daniel J. ; Yafi, Faysal A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-5a96c946a38350a3be07e5179b46bf172ff484535cafac0935e9344cb850e43b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Connective tissue diseases</topic><topic>Penis</topic><topic>Reviews</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cwikla, Daniel J.</creatorcontrib><creatorcontrib>Yafi, Faysal A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Therapeutic Advances in Urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Cwikla, Daniel J.</au><au>Yafi, Faysal A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intralesional collagenase Clostridium histolyticum in the management of Peyronie’s disease: current best practice</atitle><jtitle>Therapeutic Advances in Urology</jtitle><addtitle>Ther Adv Urol</addtitle><date>2018-04-01</date><risdate>2018</risdate><volume>10</volume><issue>4</issue><spage>139</spage><epage>153</epage><pages>139-153</pages><issn>1756-2872</issn><eissn>1756-2880</eissn><abstract>The use of Clostridium histolyticum collagenase (CCH) has become increasingly widespread for the treatment of Peyronie’s disease (PD) in recent years. Numerous trials have confirmed both its safety and efficacy in appropriately selected patients with this condition. The purpose of this review is to examine pivotal trials demonstrating the efficacy of CCH, revisit viable candidates for treatment with intralesional injection therapy, and provide a summary of injection technique and appropriate management of patients receiving this treatment at the time of therapy and in follow up.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>29560030</pmid><doi>10.1177/1756287218755020</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1756-2872
ispartof Therapeutic Advances in Urology, 2018-04, Vol.10 (4), p.139-153
issn 1756-2872
1756-2880
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5851106
source Sage Journals GOLD Open Access 2024
subjects Connective tissue diseases
Penis
Reviews
title Intralesional collagenase Clostridium histolyticum in the management of Peyronie’s disease: current best practice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A41%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intralesional%20collagenase%20Clostridium%20histolyticum%20in%20the%20management%20of%20Peyronie%E2%80%99s%20disease:%20current%20best%20practice&rft.jtitle=Therapeutic%20Advances%20in%20Urology&rft.au=Cwikla,%20Daniel%20J.&rft.date=2018-04-01&rft.volume=10&rft.issue=4&rft.spage=139&rft.epage=153&rft.pages=139-153&rft.issn=1756-2872&rft.eissn=1756-2880&rft_id=info:doi/10.1177/1756287218755020&rft_dat=%3Cproquest_AFRWT%3E2016532436%3C/proquest_AFRWT%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-5a96c946a38350a3be07e5179b46bf172ff484535cafac0935e9344cb850e43b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2313980307&rft_id=info:pmid/29560030&rft_sage_id=10.1177_1756287218755020&rfr_iscdi=true